What pooling buys you and what it destroys posts 61–84
This is a continuation of a long topic, addressed by post number rather than by page. Start at post 1 · go to the accepted answer.
Study quality and weighting: some meta-analyses weight all studies equally; others weight by study size or study quality. The choice affects the result and should be stated and justified.
Caveat: everything above assumes the paperwork is what it says it is.
Answering the question post #59 raises rather than the one it answers.
Adding the boring version of pooling buys, because the interesting version keeps getting posted and the boring one is usually right.
Check the ordinary explanations, in order, and stop when one of them accounts for what you are seeing. Most of the time the second one does.
Individual participant data pooling is a much stronger design than aggregate pooling and is rare because it requires cooperation rather than a search.
If that is already documented somewhere, ignore me and link it.
Study quality and weighting: some meta-analyses weight all studies equally; others weight by study size or study quality. The choice affects the result and should be stated and justified.
Nothing above should be read as advice about what anyone else should do.
Post #63 is the version of this I will quote in future. One addition.
On pooling buys: the maintained page in the documentation commons covers the general case with citations and a review date, which is more reliable than any reply here including this one.
Agreed on all of that, and I have nothing to add to it.
Confirming post #67 from a second method, which matters more than confirming it from a second person.
I disagree with the framing of pooling buys above, and I think it is a substantive disagreement rather than a terminological one. Setting out why, so it can be checked.
The reasoning depends on an assumption that is doing a lot of work and is never stated. If the assumption holds, the conclusion follows. I do not think it holds generally.
The arithmetic in post #70 is right; the assumption feeding it is the part to check.
Checked the pooling buys claim against the primary source this morning. It survives, with a narrower scope than the version quoted here. Posting the narrower scope.
Good question, well framed, and I would like to see it answered properly.
Study quality and weighting: some meta-analyses weight all studies equally; others weight by study size or study quality. The choice affects the result and should be stated and justified.
Post #73 put the caveat in the right place and I want to underline it.
Where the included trials share a sponsor and a protocol template, their errors correlate and pooling does not average them out.
I would not lead a decision with this, but I would not ignore it either.
A note on how pooling buys gets discussed rather than on pooling buys itself: the confident posts get the replies and the careful ones get ignored, and the careful ones have been right more often.
Worth stating the null on pooling buys before we explain it: the observation may be nothing. That possibility deserves a sentence and usually does not get one.
Post #76 and I disagree about the size of the effect, not about the direction.
The arithmetic on pooling buys is the easy part and it is where the errors are, which is an uncomfortable combination. Show your working and someone will catch it.
Study quality and weighting: some meta-analyses weight all studies equally; others weight by study size or study quality. The choice affects the result and should be stated and justified.
Collapsed as off-topic by two members at trust level 3 or above
Post #77 put the caveat in the right place and I want to underline it.
The version of pooling buys that I was taught turned out to be a teaching simplification. Useful, and not true in the way I had assumed it was.
Adding a note of thanks rather than an opinion. I did not know most of that.
Double extraction with disagreement resolution is standard and is worth checking for, because single extraction errors are common and non-random.
If anyone can point at the primary source I would be grateful.
One caution on pooling buys: everything above assumes the underlying documentation is what it claims to be. That assumption is doing real work and is rarely stated.
Suggested topics
| Topic | Participants | Replies | Views | Activity |
|---|---|---|---|---|
|
Second pass at: What pooling buys you and what it destroys
Posting this under the heading it deserves: Second pass at: What pooling buys you and what it destroys Everything below is what sits behind that. Something about pooling buys does not reconcile and I would…
|
+32 | 36 | 19k | 4mo |
|
Reading a meta-analysis you disagree with, fairly
Posting this under the heading it deserves: Reading a meta-analysis you disagree with, fairly Everything below is what sits behind that. I would like to disagree carefully with the settled view on reading a…
|
+7 | 13 | 2.5k | 23mo |
|
Coming back to: Prediction intervals and why they are more honest than confidence intervals
Prediction intervals and why they are more honest than confidence intervals Writing it up because I had to work it out twice and would rather nobody else did. Prediction intervals — I have the observation and…
|
2 | 65 | 22mo | |
|
Prediction intervals and why they are more honest than confidence intervals
Posting this under the heading it deserves: Prediction intervals and why they are more honest than confidence intervals Everything below is what sits behind that. I have spent a fortnight trying to pin…
|
+21 | 25 | 46k | 4mo |
|
Heterogeneity as information rather than as a nuisance
Posting this under the heading it deserves: Heterogeneity as information rather than as a nuisance Everything below is what sits behind that. An honest uncertainty about heterogeneity rather than a disguised…
|
+88 | 95 | 1.2k | 6mo |
Related topics — sharing the tags publication bias, risk of bias, meta-analysis
| Topic | Participants | Replies | Views | Activity |
|---|---|---|---|---|
|
Why semaglutide solutions can look faintly opalescent and when that matters
The question in the title: Why semaglutide solutions can look faintly opalescent and when that matters I will give what I have already checked below so nobody repeats it. A follow-up question about…
|
+73 | 79 | 2k | 4mo |
|
What I would record differently if I started again
Asking directly, because I could not find a straight answer: What I would record differently if I started again Asking about the phase almost nobody writes about. The material here on losing is good. The…
|
2 | 12k | 5mo | |
|
What we do not know about retatrutide, listed explicitly
The question in the title: What we do not know about retatrutide, listed explicitly I will give what I have already checked below so nobody repeats it. Setting out what I think I know about this compound and…
|
+106 | 113 | 4.8k | 17mo |
|
Revisiting: Hepatic effects of glucagon receptor agonism: the mechanistic worry
Revisiting: Hepatic effects of glucagon receptor agonism: the mechanistic worry Writing it up because I had to work it out twice and would rather nobody else did. A methods question rather than a substantive…
|
+10 | 14 | 8.4k | 16h |
|
Journal club: SURMOUNT-1, read without the press release
Journal club: SURMOUNT-1, read without the press release Writing it up because I had to work it out twice and would rather nobody else did. Posting a small dataset on SURMOUNT-1. It is mine, it is…
|
+139 | 157 | 66k | 12mo |